Evariant gets $23.7M from McKesson and Salesforce

Evariant platform

Evariant has raised $23.7 million from McKesson Ventures and Salesforce Ventures as an add-on to existing Series C round.

The company has developed a healthcare CRM and analytics solution built on Salesforce. It provides a 360-degree view of patients and physicians through big data and analytics to transform how health systems and hospitals engage with patients, consumers, and providers.

“This additional investment positions Evariant to continue to help health systems and hospitals grow revenue through strategic patient acquisition and physician alignment,” William Moschella, Co-Founder and CEO, said in a statement. “By tapping big data and analytics, healthcare leaders can turn clinical data into meaningful insights that drive proactive health, and increased profitability.”

Evariant clients include six of the top ten health systems in the United States, and more than 600 hospitals.

The company started its Series C round last year, and in December it raised a $42.3 million, bringing its total funding amount to $66 million at the time.